BioCentury | Aug 15, 2005
Tools & Techniques

The toll collectors

...also is developing agonists and antagonists, gained its TLR4 programs through the 1999 acquisition of Ribi ImmunoChem Research Inc....
BioCentury | Oct 23, 2000
Strategy

CRXA does its part for M&A

...licensing deals. Burris sees the sequence of acquisitions - GenQuest Inc., Anergen Inc. and then Ribi ImmunoChem Research Inc....
BioCentury | Oct 2, 2000
Clinical News

Melacine melanoma cell line vaccine regulatory update

...2001. CRXA obtained the vaccine, which is approved in Canada, through its 1999 acquisition of Ribi ImmunoChem Research Inc....
BioCentury | Sep 27, 2000
Company News

Corixa to file BLA for Melacine

...A (MPL) and mycobacterial cell wall. CRXA obtained the vaccine through its 1999 purchase of Ribi ImmunoChem Research Inc. BC...
BioCentury | Apr 3, 2000
Company News

Corixa, Wyeth Lederle deal

...Lederle expanded access to CRXA's monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi ImmunoChem...
BioCentury | Mar 27, 2000
Company News

Corixa and Wyeth Lederle Vaccines expand collaboration

...Lederle expanded access to its monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi ImmunoChem...
BioCentury | Oct 25, 1999
Analyst Picks & Changes

Analyst picks & changes

...III products, could provide investors with a risk diversification strategy and that the acquisition of Ribi ImmunoChem Research Inc....
BioCentury | Oct 11, 1999
Company News

Ribi ImmunoChem management update

...CRXA completes Ribi acquisition, B3) Ribi ImmunoChem Research Inc. (RIBI), Hamilton, Mont. Business: Autoimmune/Inflammation, Cancer, Infectious diseases Resigned: Robert...
BioCentury | Oct 11, 1999
Company News

Corixa, Ribi ImmunoChem deal

...outstanding after the acquisition. (CRXA deal, B3; RIBI management, B9) Corixa Corp. (CRXA), Seattle, Wash. Ribi ImmunoChem Research Inc....
BioCentury | Oct 4, 1999
Finance

3Q Market Review: Biobulls make their case

...Londonderry, N.H.), U.S. Bioscience Inc. (UBS, West Con-shohocken, Penn.), Anergen Inc. (ANRG, Redwood City, Calif.), Ribi ImmunoChem Research Inc....
...Londonderry, N.H.), U.S. Bioscience Inc. (UBS, West Con-shohocken, Penn.), Anergen Inc. (ANRG, Redwood City, Calif.), Ribi ImmunoChem Research Inc....
Items per page:
1 - 10 of 65
BioCentury | Aug 15, 2005
Tools & Techniques

The toll collectors

...also is developing agonists and antagonists, gained its TLR4 programs through the 1999 acquisition of Ribi ImmunoChem Research Inc....
BioCentury | Oct 23, 2000
Strategy

CRXA does its part for M&A

...licensing deals. Burris sees the sequence of acquisitions - GenQuest Inc., Anergen Inc. and then Ribi ImmunoChem Research Inc....
BioCentury | Oct 2, 2000
Clinical News

Melacine melanoma cell line vaccine regulatory update

...2001. CRXA obtained the vaccine, which is approved in Canada, through its 1999 acquisition of Ribi ImmunoChem Research Inc....
BioCentury | Sep 27, 2000
Company News

Corixa to file BLA for Melacine

...A (MPL) and mycobacterial cell wall. CRXA obtained the vaccine through its 1999 purchase of Ribi ImmunoChem Research Inc. BC...
BioCentury | Apr 3, 2000
Company News

Corixa, Wyeth Lederle deal

...Lederle expanded access to CRXA's monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi ImmunoChem...
BioCentury | Mar 27, 2000
Company News

Corixa and Wyeth Lederle Vaccines expand collaboration

...Lederle expanded access to its monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi ImmunoChem...
BioCentury | Oct 25, 1999
Analyst Picks & Changes

Analyst picks & changes

...III products, could provide investors with a risk diversification strategy and that the acquisition of Ribi ImmunoChem Research Inc....
BioCentury | Oct 11, 1999
Company News

Ribi ImmunoChem management update

...CRXA completes Ribi acquisition, B3) Ribi ImmunoChem Research Inc. (RIBI), Hamilton, Mont. Business: Autoimmune/Inflammation, Cancer, Infectious diseases Resigned: Robert...
BioCentury | Oct 11, 1999
Company News

Corixa, Ribi ImmunoChem deal

...outstanding after the acquisition. (CRXA deal, B3; RIBI management, B9) Corixa Corp. (CRXA), Seattle, Wash. Ribi ImmunoChem Research Inc....
BioCentury | Oct 4, 1999
Finance

3Q Market Review: Biobulls make their case

...Londonderry, N.H.), U.S. Bioscience Inc. (UBS, West Con-shohocken, Penn.), Anergen Inc. (ANRG, Redwood City, Calif.), Ribi ImmunoChem Research Inc....
...Londonderry, N.H.), U.S. Bioscience Inc. (UBS, West Con-shohocken, Penn.), Anergen Inc. (ANRG, Redwood City, Calif.), Ribi ImmunoChem Research Inc....
Items per page:
1 - 10 of 65